他泽司他不同版本一盒的最新价格公布

Tazerestat (TAZVERIK) is a targeted drug for specific cancers, mainly used to treat epithelioid sarcoma and relapsed or refractory follicular lymphoma. This article will introduce the relevant information of tazerestat in detail from three aspects: price, domestic marketing status and efficacy, to help patients and their families better understand this drug.

The latest prices for a box of different versions of tazerestat

There are many versions around the world, and the prices vary depending on the manufacturer and specifications. The following is the latest price information for several major versions currently on the market.

Laos Lucius Version

The specification of Tazerestat produced by Laos Lucius is 200mg*56 tablets/box, with a reference price of approximately US$777. This version is relatively inexpensive and suitable for patients on a budget.

Laos Big Bear Version

The specifications of Tazerestat produced by Laos Big Bear are 200mg*80 tablets/box, and the reference price is about US$1,480. Although the price is higher, each box contains more pieces and the price/performance ratio is relatively good.

Export original research version of medicine to Hong Kong

The specification of original research version of medicine exported to Hong Kong is 200mg*240 tablets/box, and the reference price is about US$7,213. This version is suitable for patients who require long-term medication, but is more expensive.

Patients should pay attention to the authenticity of drugs when purchasing, choose regular channels, and avoid buying fake or inferior drugs.

Tazerestat’s domestic marketing status

Tazerestat has not yet been officially launched in mainland China, nor has it been included in the medical insurance catalog. If patients need to use it, they need to obtain it through other means.

Purchase channels

Patients can purchase tazetostat through formal medical service institutions or cross-border e-commerce platforms. When purchasing, you need to carefully check the production date, packaging integrity and other information of the drug to ensure the quality of the drug.

The current situation of generic drugs

Since the original drugs have not yet been launched in China, there are many generic drugs on the market. When choosing generic drugs, patients should give priority to reputable manufacturers and consult their doctors for advice.

In the future, with the progress of tazerestat’s approval in China, patients are expected to obtain this drug through more convenient ways.

Efficacy of tazerestat

Tazerestat is a targeted drug targeting EZH2 gene mutations and has shown significant effects in the treatment of specific cancers.

Therapeutic effect of epithelioid sarcoma

Tazerestat is suitable for patients 16 years of age and older with unresectable metastatic or locally advanced epithelioid sarcoma. Clinical data shows that the drug can effectively alleviate the condition and improve the patient's quality of life.

Therapeutic effect of follicular lymphoma

Tazerestat also shows good efficacy in patients with relapsed or refractory follicular lymphoma. Especially for patients with positive EZH2 mutations, the therapeutic effect is more significant.

When using tazerestat, patients must strictly follow medical instructions and regularly monitor their physical condition to prevent possible adverse reactions.